If You'd Invested $1,000 in DexCom 10 Years Ago, Here's How Much You'd Have Today

Shares of DexCom (NASDAQ: DXCM), a medical device specialist, have lagged the market this year. However, the true test of a company isn't how it performs over a relatively short period, such as eight months. Anything can happen in the short run that makes even the best businesses stumble. Top stocks, however, can consistently outperform broader equities over long periods, such as a decade. With that said, let's look at how DexCom has performed over the past 10 years and try to determine what kinds of returns it can deliver from here on out.Image source: Getty Images.DexCom develops and markets continuous glucose monitoring (CGM) systems, a type of device that continuously tracks blood sugar levels. The technology isn't exactly new anymore, and it has enjoyed increased adoption over the past decade, partly thanks to DexCom's efforts. The company is a leader in this niche. DexCom's revenue has grown rapidly over this period, too, and the company managed to turn profitable. But a significant pullback over the past few years has destroyed some of its long-term gains. The result? Though DexCom's returns over the past 10 years haven't been terrible at all, they are below the performance of the S&P 500 over the same period.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool